Changes in cardiac diastolic dimensions precede hypertrophy in early stages of hypertension

C Lemme1, K Lindvall, U de Faire

  • 1Department of Medicine, Karolinska Hospital, Stockholm, Sweden.

Insights

Left ventricular hypertrophy (LVH) did not increase in borderline hypertensive men over 3 years. However, cardiac dimensions and stress increased, suggesting these changes precede LVH development.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • Left ventricular hypertrophy (LVH) is a key indicator of hypertensive target organ damage.
  • LVH predicts major cardiovascular events like myocardial infarction and stroke.
  • Longitudinal data on LVH development in hypertension is limited.

Purpose of the Study:

  • To investigate the longitudinal changes in left ventricular hypertrophy (LVH) and related cardiac parameters in men with borderline hypertension.
  • To determine if early cardiac structural and functional changes precede the development of LVH in this population.

Main Methods:

  • A 3-year longitudinal study of 66 men with borderline hypertension (diastolic BP 85-94 mm Hg).
  • M-mode echocardiography performed at baseline and after 3 years.
  • Anthropometrical data, including body mass index (BMI), were recorded.

Main Results:

  • No significant increase in LVH indices was observed over the 3-year study period.
  • Statistically significant increases in aortic root dimension, left atrial diameter in diastole (LADD), left ventricular diameter in diastole (LVDD), and peak systolic wall stress (PSWS) were noted.
  • A significant decrease in left ventricular ejection time (LVET) was observed, alongside correlations between baseline BP and PSWS, and BMI and LV mass/wall thickness.

Conclusions:

  • LVH indices did not progress in borderline hypertensive men over 3 years.
  • Increases in aortic root dimension, LADD, LVDD, and PSWS, along with shortened LVET, suggest these changes may precede LVH.
  • Body mass index (BMI) demonstrated a stronger correlation with LVH indices than blood pressure levels.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...